questionText: To ask the Secretary of State for Health and Social Care, what steps are required for vaccines for the prevention of recurrent urinary tract infections to obtain regulatory approval including an indicative timeline for licensing.
answerText: For any new medicine to be introduced to the United Kingdom market an application to the Medicines and Healthcare products Regulatory Agency (MHRA) is required. The MHRA is ready to support companies that are looking to introduce new medicines to the Unit...
heading: Urinary Tract Infections: Vaccination